Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 51 - 100 av 210 resultater
Tid
Selskap
Tittel
Sektor
Kategori
06 Mar 2024
18:00 CET
ADOCIA
ADOCIA Announces Its Participation at Key Events
20103010 Biotechnology
Other subject
06 Mar 2024
18:00 CET
ADOCIA
ADOCIA annonce sa participation à des évènements clés
20103010 Biotechnology
Other subject
27 Feb 2024
18:00 CET
ADOCIA
ADOCIA Reports Fourth Quarter 2023 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
27 Feb 2024
18:00 CET
ADOCIA
ADOCIA publie ses résultats financiers du 4ème trimestre 2023 et fait le point sur ses activités
20103010 Biotechnology
Other subject
13 Feb 2024
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 janvier 2024
20103010 Biotechnology
Other subject
13 Feb 2024
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of January 31st, 2024
20103010 Biotechnology
Other subject
25 Jan 2024
18:00 CET
ADOCIA
ADOCIA annonce son calendrier financier pour l’année 2024
20103010 Biotechnology
Other subject
25 Jan 2024
18:00 CET
ADOCIA
ADOCIA Announces its Financial Calendar for 2024
20103010 Biotechnology
Other subject
17 Jan 2024
18:00 CET
ADOCIA
ADOCIA Announces Half Year Report on Adocia’s Liquidity Agreement With Kepler Capital Markets
20103010 Biotechnology
Other subject
17 Jan 2024
18:00 CET
ADOCIA
ADOCIA annonce le bilan semestriel du contrat de liquidité conclu avec la société Kepler Capital Markets
20103010 Biotechnology
Other subject
16 Jan 2024
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 décembre 2023
20103010 Biotechnology
Other financial transaction
16 Jan 2024
18:00 CET
ADOCIA
Number of shares and voting rights of ADOCIA as of December 31st, 2023
20103010 Biotechnology
Other financial transaction
15 Dec 2023
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of November 30th, 2023
20103010 Biotechnology
Other subject
15 Dec 2023
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 novembre 2023
20103010 Biotechnology
Other subject
23 Nov 2023
18:00 CET
ADOCIA
Adocia : Mise à Disposition de la Lettre aux Actionnaires
20103010 Biotechnology
Other subject
23 Nov 2023
18:00 CET
ADOCIA
Adocia Publishes its Letter to Shareholders
20103010 Biotechnology
Other subject
15 Nov 2023
18:00 CET
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of October 31st, 2023
20103010 Biotechnology
Other subject
15 Nov 2023
18:00 CET
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 octobre 2023
20103010 Biotechnology
Other subject
09 Nov 2023
18:00 CET
ADOCIA
ADOCIA Revealed Promising Preclinical Data on AdoShell® Islets for Cell Therapy of Diabetes
20103010 Biotechnology
Other subject
09 Nov 2023
18:00 CET
ADOCIA
ADOCIA dévoile des données précliniques prometteuses sur AdoShell® Islets pour la thérapie cellulaire du diabète
20103010 Biotechnology
Other subject
25 Oct 2023
18:00 CEST
ADOCIA
ADOCIA Reports Financial Results of Third Quarter 2023 and Provides an Update on its Activities
20103010 Biotechnology
Other subject
25 Oct 2023
18:00 CEST
ADOCIA
ADOCIA publie ses résultats financiers du troisième trimestre 2023 et fait le point sur ses activités
20103010 Biotechnology
Other subject
23 Oct 2023
09:00 CEST
ADOCIA
ADOCIA’s Partner Tonghua Dongbao Announces Positive Results of Three Clinical Trials on BioChaperone® Combo
20103010 Biotechnology
Other subject
23 Oct 2023
09:00 CEST
ADOCIA
ADOCIA et son partenaire Tonghua Dongbao annoncent les résultats positifs de trois essais cliniques sur BioChaperone® Combo
20103010 Biotechnology
Other subject
12 Oct 2023
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 septembre 2023
20103010 Biotechnology
Other subject
12 Oct 2023
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of September 30th, 2023
20103010 Biotechnology
Other subject
25 Sep 2023
18:00 CEST
ADOCIA
ADOCIA Announces Oral Presentations on AdoShell® Islets at EASD and IPITA-IXA-CTRMS Congresses
20103010 Biotechnology
Meetings / events
25 Sep 2023
18:00 CEST
ADOCIA
ADOCIA annonce des présentations orales sur AdoShell® Islets à l’occasion des congrès de l’EASD et de l’IPITA-IXA-CTRMS
20103010 Biotechnology
Meetings / events
18 Sep 2023
18:00 CEST
ADOCIA
ADOCIA Announces First Half 2023 Financial Results and Provides a Business Update
20103010 Biotechnology
Other subject
18 Sep 2023
18:00 CEST
ADOCIA
ADOCIA publie ses résultats financiers du premier semestre 2023 et dresse un bilan de ses activités
20103010 Biotechnology
Other subject
14 Sep 2023
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 août 2023
20103010 Biotechnology
Other subject
14 Sep 2023
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of August 31St, 2023
20103010 Biotechnology
Other subject
13 Sep 2023
21:34 CEST
ADOCIA
ADOCIA annonce la mise à disposition d’un prospectus à l’occasion de l’admission aux négociations d’actions émises et susceptibles d’être émises au profit d’IPF Partners sur exercice de ses BSA
20103010 Biotechnology
Other subject
13 Sep 2023
21:34 CEST
ADOCIA
ADOCIA Announces the Availability of a Prospectus for the Admission to Trading of Shares Issued or Likely to Be Issued to IPF Partners on Exercise of Its Warrants
20103010 Biotechnology
Other subject
31 Aug 2023
18:00 CEST
ADOCIA
ADOCIA Announces that it has Received €500.000 in Proceeds from a Partial Exercise of Warrants Held by IPF Partners
20103010 Biotechnology
Other subject
31 Aug 2023
18:00 CEST
ADOCIA
ADOCIA annonce l’encaissement de 500 000 euros au titre de l’exercice par IPF Partners d’une partie de ses Bons de Souscription d’Actions
20103010 Biotechnology
Other subject
30 Aug 2023
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 31 juillet 2023
20103010 Biotechnology
Other subject
30 Aug 2023
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of July 31st, 2023
20103010 Biotechnology
Other subject
31 Jul 2023
18:00 CEST
ADOCIA
ADOCIA annonce le bilan semestriel du contrat de liquidité conclu avec la société Kepler Capital Markets
20103010 Biotechnology
Other subject
31 Jul 2023
18:00 CEST
ADOCIA
ADOCIA Announces Half year report on Adocia’s liquidity agreement with Kepler Capital Markets
20103010 Biotechnology
Other subject
27 Jul 2023
18:00 CEST
ADOCIA
ADOCIA Announces the Availability of a Prospectus for its Capital Increase and Convertible Bond Issue
20103010 Biotechnology
Other subject
27 Jul 2023
18:00 CEST
ADOCIA
ADOCIA annonce la mise à disposition d’un prospectus dans le cadre de son augmentation de capital et émission d’obligations convertibles
20103010 Biotechnology
Other subject
26 Jul 2023
00:01 CEST
ADOCIA
ADOCIA annonce ses résultats financiers du 2ème trimestre 2023 et un financement de 10 millions d’euros
20103010 Biotechnology
Other subject
26 Jul 2023
00:01 CEST
ADOCIA
ADOCIA Announces Q2 2023 Financial Results and a €10 Million Financing Operation
20103010 Biotechnology
Other subject
18 Jul 2023
18:00 CEST
ADOCIA
ADOCIA confirms its eligibility for the PEA–PME
20103010 Biotechnology
Other subject
18 Jul 2023
18:00 CEST
ADOCIA
ADOCIA confirme son éligibilité au PEA-PME
20103010 Biotechnology
Other subject
12 Jul 2023
18:00 CEST
ADOCIA
Number of Shares and Voting Rights of ADOCIA as of June 30th, 2023
20103010 Biotechnology
Other subject
12 Jul 2023
18:00 CEST
ADOCIA
ADOCIA : Information relative au nombre d'actions et de droits de vote en date du 30 juin 2023
20103010 Biotechnology
Other subject
05 Jul 2023
18:30 CEST
ADOCIA
ADOCIA accorde à Sanofi un droit exclusif de négociation d’un partenariat sur M1Pram pour 10 millions d'euros et obtient l’engagement d’investisseurs pour une levée de fonds de 10 millions d’euros
20103010 Biotechnology
New
05 Jul 2023
18:30 CEST
ADOCIA
ADOCIA Grants Sanofi an Exclusive Right to Negotiate a Partnership on M1Pram for 10 Million Euros and Obtains Commitment from Investors to Provide 10 Million Euros in Financing
20103010 Biotechnology
New
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva